Select language
English
English German Spanish Italian French

General

Lupin Neurosciences is committed to working with Healthcare Professionals to develop science-based solutions that stretch beyond access to lifechanging treatment options to optimize patient care in underserved neurological diseases.
Portfolio
  • NaMuscla®
    • Pipeline
  • Overview
    • Publications
  • 2023 Congresses
  • 2024 Congress
    • General
  • Medical Inquiries & Adverse Event Reporting
  • Transparency Reporting
    • Dang U. et al. Age, family history and genetic testing data from myotonic dystrophy patients and carers participating in ENSA survey; P65